Clinical Trial Update: Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial comparing fixed-dose dolutegravir/lamivudine to the two drugs given separately in people with HIV infection; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir/Lamivudine (dolutegravir/lamivudine)
• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED | Results posted: 2019-02-21